p.63 抽出テキスト

175. Topkara VK, Dang NC, Barili F, et al. Predictors and outcomes of continuous veno-venous hemodialysis use after implantation of a left ventricular assist device. J Heart Lung Transplant 2006; 25: 404-408. PMID: 16563969 176. Pawar M, Mehta Y, Kapoor P, et al. Central venous catheter-related blood stream infections: incidence, risk factors, outcome, and associated pathogens. J Cardiothorac Vasc Anesth 2004; 18: 304-308. PMID: 15232809 177. Kanjanahattakij N, Horn B, Abdulhadi B, et al. Blood stream infection is associated with cerebrovascular accident in patients with left ventricular assist device: a systematic review and meta-analysis. J Artif Organs 2018; 21: 271-277. PMID: 29546615 178. Yoshioka D, Sakaniwa R, Toda K, et al. Relationship Between Bacteremia and Hemorrhagic Stroke in Patients With Continuous-Flow Left Ventricular Assist Device. Circ J 2018; 82: 448-456. PMID: 28943532 179. Barbara DW, Olsen DA, Pulido JN, et al. Periprocedural Management of 172 Gastrointestinal Endoscopies in Patients with Left Ventricular Assist Devices. ASAIO J 2015; 61: 670-675. PMID: 26181710 180. Stern DR, Kazam J, Edwards P, et al. Increased incidence of gastrointestinal bleeding following implantation of the HeartMate II LVAD. J Card Surg 2010; 25: 352-356. PMID: 20331479 181. Kawabori M, Kurihara C, Critsinelis AC, et al. Gastrointestinal Bleeding After HeartMate II or HVAD Implantation: Incidence, Location, Etiology, and Effect on Survival. ASAIO J 2020; 66: 283- 290. PMID: 30973400 182. Mohamedali B, Yost G, Bhat G. Is Diabetes Mellitus a Risk Factor for Poor Outcomes after Left Ventricular Assist Device Placement? Tex Heart Inst J 2017; 44: 115-119. PMID: 28461796 183. Siméon S, Flécher E, Revest M, et al. Left ventricular assist devicerelated infections: a multicentric study. Clin Microbiol Infect 2017; 23: 748-751. PMID: 28323195 184. Yen DC, Watson MH, Burgess LD, et al. Positive Impact of Continuous-Flow Left Ventricular Assist Device Implantation on Glycemic Control in Patients with Type 2 Diabetes Mellitus and Advanced Chronic Systolic Heart Failure. Pharmacotherapy 2016; 36: 1210- 1216. PMID: 27779786 185. Vest AR, Mistak SM, Hachamovitch R, et al. Outcomes for Patients With Diabetes After Continuous-Flow Left Ventricular Assist Device Implantation. J Card Fail 2016; 22: 789-796. PMID: 26924520 186. Volkovicher N, Kurihara C, Critsinelis A, et al. Effect of obesity on outcomes in patients undergoing implantation of continuous-flow left ventricular assist devices. J Artif Organs 2018; 21: 180-187. PMID: 29372417 187. Lee AY, Tecson KM, Lima B, et al. Durable left ventricular assist device implantation in extremely obese heart failure patients. Artif Organs 2019; 43: 234-241. PMID: 30357882 188. Mohamedali B, Yost G, Bhat G. Obesity as a Risk Factor for Consideration for Left Ventricular Assist Devices. J Card Fail 2015; 21: 800-805. PMID: 26093334 189. Munoz E, Lonquist JL, Radovancevic B, et al. Long-term results in diabetic patients undergoing heart transplantation. J Heart Lung Transplant 1992; 11: 943-949. PMID: 1420243 190. Carr JG, Stevenson LW, Walden JA, et al. Prevalence and hemodynamic correlates of malnutrition in severe congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 1989; 63: 709-713. PMID: 2923059 191. Mancini DM, Walter G, Reichek N, et al. Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure. Circulation 1992; 85: 1364-1373. PMID: 1555280 192. Freeman LM, Roubenoff R. The nutrition implications of cardiac cachexia. Nutr Rev 1994; 52: 340-347. PMID: 7816351 193. Schwengel RH, Gottlieb SS, Fisher ML. Protein-energy malnutrition in patients with ischemic and nonischemic dilated cardiomyopathy and congestive heart failure. Am J Cardiol 1994; 73: 908-910. PMID: 8184823 194. Mano A, Fujita K, Uenomachi K, et al. Body mass index is a useful predictor of prognosis after left ventricular assist system implantation. J Heart Lung Transplant 2009; 28: 428-433. PMID: 19416769 195. Saito A, Amiya E, Hatano M, et al. Controlling Nutritional Status Score As a Predictive Marker for Patients With Implantable Left Ventricular Assist Device. ASAIO J 2020; 66: 166-172. PMID: 30913100 196. Uribarri A, Rojas SV, Hanke JS, et al. Prognostic Value of the Nutritional Risk Index in Candidates for Continuous Flow Left Ventricular Assist Device Therapy. Rev Esp Cardiol (Engl Ed) 2019; 72: 608- 615. PMID: 30078744 197. Critsinelis AC, Kurihara C, Kawabori M, et al. Preoperative Prealbumin Level as a Predictor of Outcomes in Patients Who Underwent Left Ventricular Assist Device Implantation. Am J Cardiol 2017; 120: 1998-2002. PMID: 28958451 198. Yost G, Tatooles A, Bhat G. Preoperative Nutritional Assessment with the Prognostic Nutrition Index in Patients Undergoing Left Ventricular Assist Device Implantation. ASAIO J 2018; 64: 52-55. PMID: 28692526 199. Casida JM, Davis JE, Pagani FD, et al. Sleep and self-care correlates before and after implantation of a left-ventricular assist device (LVAD). J Artif Organs 2018; 21: 278-284. PMID: 29651631 200. Casida JM, Brewer RJ, Smith C, et al. An exploratory study of sleep quality, daytime function, and quality of life in patients with mechanical circulatory support. Int J Artif Organs 2012; 35: 531-537. PMID: 22661110 201. 山中源治,井上智子.補助人工心臓と共に生きる:心臓移植待機患者の体験と看護支援への示唆.日クリティカルケア看会誌 2014; 10: 28-40. 202. 山中源治.在宅療養に移行する植込型補助人工心臓患者および主介護者の体験と看護支援の検討.日クリティカルケア看会誌 2016; 12: 25-37. 203. WHO. Global Atlas of Palliative Care at the End of Life. 2014. https://www.who.int/nmh/Global_Atlas_of_Palliative_Care.pdf 204. Detering KM, Hancock AD, Reade MC, et al. The impact of advance care planning on end of life care in elderly patients: randomised controlled trial. BMJ 2010; 340: c1345. PMID: 20332506 205. Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 2016; 37: 2129-2200. PMID: 27206819 206. 日本救急医学会,日本集中治療医学会,日本循環器学会.救急・集中治療における終末期医療に関するガイドライン~3 学会からの提言~.2014.https://www.jaam.jp/info/2014/pdf/info-20141104_ 02_01_02.pdf 207. Kavarana MN, Pessin-Minsley MS, Urtecho J, et al. Right ventricular dysfunction and organ failure in left ventricular assist device recipients: a continuing problem. Ann Thorac Surg 2002; 73: 745-750. PMID: 11899176 208. 日本心臓リハビリテーション学会.心不全の心臓リハビリテーション標準プログラム(2017年版).http://www.jacr.jp/web/wp-content/ uploads/2015/04/shinfuzen2017_2.pdf 209. Slaughter MS, Pagani FD, Rogers JG, et al. HeartMate II Clinical Investigators. Clinical management of continuous-flow left ventricular assist devices in advanced heart failure. J Heart Lung Transplant 2010; 29 Suppl: S1-39. PMID: 20181499 210. Cook JL, Colvin M, Francis GS, et al. American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology, Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation, Council on Cardiovascular Disease in the Young, et al. Recommendations for the Use of Mechanical Circulatory Support: Ambulatory and Community Patient Care: A Scientific Statement From the American Heart Association. Circulation 2017; 135: e1145-e1158. PMID: 28559233 211. Heart Failure Society of America. Section 10: Surgical approaches to the treatment of heart failure. J Card Fail 2006; 12: e76-e79. PMID: 16500574 212. Pawale A, Schwartz Y, Itagaki S, et al. Selective implantation of durable left ventricular assist devices as primary therapy for refractory cardiogenic shock. J Thorac Cardiovasc Surg 2018; 155: 1059-1068. PMID: 29274911 213. Seguchi O, Fujita T, Watanabe T, et al. Temporary biventricular support with extracorporeal membrane oxygenation: a feasible therapeutic approach for cardiogenic shock with multiple organ failure. J Artif Organs 2017; 20: 206-214. PMID: 28567581 214. Yoshitake S, Kinoshita O, Nawata K, et al. Single-center experience of the bridge-to-bridge strategy using the Nipro paracorporeal ventricular assist device. J Artif Organs 2018; 21: 405-411. PMID: 29943370 215. Kirklin JK, Naftel DC, Kormos RL, et al. The Fourth INTERMACS Annual Report: 4,000 implants and counting. J Heart Lung Transplant 2012; 31: 117-126. PMID: 22305376 216. Imamura T, Kinugawa K, Shiga T, et al. Early decision for a left ventricular assist device implantation is necessary for patients with modifier A. J Artif Organs 2012; 15: 301-304. PMID: 22527979 217. Yoshioka D, Matsumiya G, Toda K, et al. Clinical results with Jarvik 2000 axial flow left ventricular assist device: Osaka University Experience. J Artif Organs 2014; 17: 308-314. PMID: 25048655 218. McGee E Jr, Danter M, Strueber M, et al. Evaluation of a lateral thoracotomy implant approach for a centrifugal-flow left ventricular assist device: The LATERAL clinical trial. J Heart Lung Transplant 2019; 38: 344-351. PMID: 30945636 219. Maltais S, Kilic A, Nathan S, et al. PREVENT Study Investigators.